The EDAN SE-18: Why 18-Lead ECG is Reshaping Cardiac Diagnostics in China


EDAN SE-18 18-Lead ECG Workstation

As Chinese hospitals push for earlier detection of myocardial infarction, the shift from 12-lead to 18-lead ECG systems is no longer optional—it is becoming standard procurement protocol.

The EDAN SE-18 is one of the first commercially available workstations to support 18-lead, 15-lead, 12-lead, and 9-lead configurations in a single device. That flexibility matters less for its technical breadth than for what it implies clinically: coverage of the right ventricle and posterior wall, two areas routinely missed by standard systems.

Real-time 18-lead sampling allows the SE-18 to flag ST-segment elevation patterns associated with posterior or right-sided infarctions. For emergency departments managing chest pain triage, the difference between a missed diagnosis and a confirmed occlusion often comes down to lead placement—and the SE-18’s color-coded, plug-and-play lead wires with signal quality LEDs reduce that margin of error.

The workstation also integrates advanced clinical tools—HRV, vector cardiography, signal-averaged ECG, and pharma study protocols—that would otherwise require separate systems. Paperless reporting and on-screen measurement editing streamline workflow, particularly relevant for cardiology departments managing high patient volumes under tight reporting timelines.

From a procurement perspective, the SE-18’s modular design—anchored by a unique sampling box that decouples acquisition from display—lowers hardware redundancy costs. One workstation can serve multiple ICU bays or outpatient clinics, a practical advantage for tier-2 and tier-3 hospitals in China seeking to upgrade cardiac diagnostic capacity without full infrastructure overhauls.

EDAN, a Shenzhen-based manufacturer with established distribution across Asia and Europe, has positioned this device at the intersection of clinical specificity and hardware efficiency. It is not a flagship research tool. It is a workhorse designed for the realities of high-throughput cardiac care in emerging hospital systems.

The SE-18 reflects a broader trend: Chinese diagnostic equipment makers are moving beyond cost arbitrage into feature-led differentiation, particularly in areas where Western incumbents have been slow to offer multi-lead flexibility at comparable price points.

Why it matters:
For procurement managers upgrading cardiac diagnostic units, the EDAN SE-18 offers a path to 18-lead capability without requiring separate devices for posterior and right-sided views. For operators, it reduces setup errors and reporting lag—two variables that directly affect patient outcomes in acute settings.


View Product →


ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.

Follow ScientificChina for deeper insight into the infrastructure behind global innovation.

Visit ScientificChina.

Home Shop Cart Account
Shopping Cart (0)

No products in the cart. No products in the cart.